Acrivon Therapeutics, Inc. (ACRV) Tops Q1 EPS by 13c

Acrivon Therapeutics, Inc. (NASDAQ: ACRV) reported Q1 EPS of ($0.49), $0.13 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Acrivon Therapeutics, Inc. (ACRV) click here.

You May Also Be Interested In

• Citigroup set to join top banks in Anthropic IPO - Bloomberg
• RBC Capital Assumes Pepper Money Ltd (PPM:AU) at Sector Perform
• Morgan Stanley Starts Adani Green Energy (ADANIGR:IN) at Overweight